US Broker Ratings

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 22% Upside Potential

Investors in the biotech space are closely monitoring Travere Therapeutics, Inc. (NASDAQ: TVTX), a company that has carved a niche in addressing rare kidney and metabolic diseases. With a market..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking a 61.87% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) is standing at an intriguing juncture for biotechnology investors. With a significant market capitalization of $5.23 billion, this Switzerland-based company is making waves in the..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 201% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is a name that has been catching the eye of investors in the healthcare sector, particularly those focusing on biotechnology. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Remarkable 180% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing opportunity for investors searching for growth in the healthcare sector. With a market capitalization of $1.64 billion, Alignment Healthcare is a significant..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring the 22.64% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has emerged as a compelling player in the biotechnology sector, boasting a market capitalization of $9.22 billion. Headquartered in Newark, California, Protagonist is at the..

Schrodinger, Inc. (SDGR) Stock Analysis: Unpacking Potential in Health Information Services Amid Market Challenges

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling case for investors navigating the healthcare sector, particularly within the niche of health information services. The company, with a market capitalization of $2.21..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 35% Upside Potential in the Biotech Sector

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing significant attention in the biotechnology sector with its promising therapeutic pipeline and potential for robust growth. With its current market cap standing at..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Potential 74% Upside for Healthcare Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands at a compelling crossroads for investors, particularly those with a focus on the healthcare sector. With a market cap of $2.64 billion, the..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy with 83% Upside Potential

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking growth and value. Headquartered in Kennesaw, Georgia,..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a Significant 70.82% Potential Upside

In the dynamic landscape of healthcare technology, Omnicell, Inc. (NASDAQ: OMCL) emerges as a pivotal player. With a market capitalization of $1.54 billion, the company is strategically positioned in the..

SS Innovations International (SSII) Stock Analysis: A Potential 142% Upside in the Healthcare Sector

SS Innovations International, Inc. (SSII), a pioneering entity in the healthcare sector, specifically in medical devices, has captured investor attention with its innovative approach to surgical robotics. Headquartered in Gurugram,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring the 3.21% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE), a healthcare innovator in the medical instruments and supplies industry, is garnering attention with its promising technologies and an attractive potential upside. Headquartered in Miami,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating Market Volatility with Unique Product Offerings

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in the development, manufacturing, and marketing of both generic and proprietary injectable, inhalation, and intranasal products. Headquartered..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 111% Potential Upside in the Healthcare Sector

For investors keeping a keen eye on the medical device industry, Enovis Corporation (NYSE: ENOV) presents a compelling opportunity. With a substantial market cap of $1.05 billion, this United States-based..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A 71.89% Potential Upside Sparks Investor Interest

Denali Therapeutics Inc. (NASDAQ: DNLI), a notable player in the biotechnology sector, is attracting significant attention from individual investors due to its promising portfolio targeting neurodegenerative and lysosomal storage diseases...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Potential Upside of 94.67% for Biotech Innovator

Investors with an eye on the biotechnology sector might find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) a compelling opportunity, given its focus on rare and ultra-rare genetic diseases. With a market..

Neogen Corporation (NEOG) Stock Analysis: Evaluating Growth Potential in the Medical Devices Sector

Neogen Corporation (NASDAQ: NEOG), a pivotal player in the healthcare sector, specifically within the medical devices industry, offers a unique value proposition for investors focused on food and animal safety..

Haemonetics Corporation (HAE) Stock Analysis: A Strong Buy Signal with a 5.4% Upside Potential

Haemonetics Corporation (NYSE: HAE), a leader in the healthcare sector’s medical devices industry, is drawing significant attention from investors. With a solid market capitalization of $4.81 billion, this Boston-based company..

AdaptHealth Corp. (AHCO) Stock Analysis: High Potential Upside with Strong Buy Consensus

AdaptHealth Corp. (NASDAQ: AHCO), a significant player in the healthcare sector specializing in medical devices, presents a compelling investment case for those looking at high potential upside opportunities. Despite the..

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating a Genomic Pioneer with a 5.25% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a leader in the genomics field, continues to capture investor attention with its innovative approach to genetic testing and diagnostics. As an integral player in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds